Caris Life Sciences, Inc. Common Stock (CAI)
NASDAQ
Closed
Oct 6, 2026
Day's Range
27.2952 wk Range
14.19Overview - CAI - Caris Life Sciences, Inc. Common Stock
Key Statistics
Valuation
Enterprise Value
8.31B
P/E (Trailing)
‪2.95‬
P/E (Forward)
‪75.48‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪8.09‬
Price / Book
‪13.53‬
EV / EBITDA
‪47.78‬
Profitability
Gross Margin
‪68.10%‬
Profit Margin
‪10.62%‬
Operating Margin
‪10.21%‬
Return on Assets
‪8.76%‬
Return on Equity
‪20.12%‬
Ownership
Shares Outstanding
282.58M
Float
134.86M
Short % of Shares Outstanding
‪11.58%‬
Held by Insiders
‪48.79%‬
Held by Institutions
‪56.41%‬
Price stats
50-Day Avg
‪23.94‬
200-Day Avg
‪21.20‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
14 analysts
Average price target
‪$ 27.00‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CAI - Caris Life Sciences, Inc. Common Stock
Peers - CAI - Caris Life Sciences, Inc. Common Stock
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- CAINASDAQCaris Life Sciences, Inc. Common Stock7.99BMarket Cap-15.94%52-week change2.96P/E (Trailing)‪10.62%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - CAI - Caris Life Sciences, Inc. Common Stock
About
Caris Life Sciences, Inc. Common Stock is the equity of Caris Life Sciences, a precision medicine and diagnostics company focused on molecular profiling and anatomic pathology services. The company uses advanced molecular information and artificial intelligence to help support cancer detection, disease…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
